Researchers watch how well SBRT works for liver and pancreatic tumors

NCT ID NCT07407257

First seen Feb 15, 2026 · Last updated May 06, 2026 · Updated 8 times

Summary

This study looked at 65 adults with liver tumors, liver metastases, or pancreatic tumors who received a type of radiation called stereotactic body radiotherapy (SBRT). The goal was to monitor how safe and effective the treatment was and to improve the process. No new treatment was tested; instead, the study observed standard care to gather information.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Institute of Oncology Ljubljana

    Ljubljana, 1000, Slovenia

Conditions

Explore the condition pages connected to this study.